Indivior Plc Ordinary Stock Today
| INDV Stock | 11.65 0.01 0.09% |
Performance15 of 100
| Odds Of DistressLess than 24
|
Indivior PLC is selling for under 11.65 as of the 18th of January 2025; that is 0.09 percent down since the beginning of the trading day. The stock's lowest day price was 11.56. Indivior PLC has about a 24 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 20th of October 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 29th of December 2014 | Category Healthcare | Classification Health Care |
Indivior PLC is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 124.63 M outstanding shares of which 1.22 M shares are currently shorted by private and institutional investors with about 0.98 trading days to cover. More on Indivior PLC Ordinary
Moving together with Indivior Stock
Moving against Indivior Stock
Indivior Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Mark Crossley | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Biotechnology, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indivior PLC can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Indivior PLC's financial leverage. It provides some insight into what part of Indivior PLC's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indivior PLC Ordinary (INDV) is traded on NASDAQ Exchange in USA. It is located in 10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235 and employs 1,000 people. Indivior PLC is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.45 B. Indivior PLC Ordinary conducts business under Biotechnology sector and is part of Health Care industry. The entity has 124.63 M outstanding shares of which 1.22 M shares are currently shorted by private and institutional investors with about 0.98 trading days to cover.
Indivior PLC generates negative cash flow from operations
Check Indivior PLC Probability Of Bankruptcy
Ownership AllocationIndivior PLC Ordinary has a total of 124.63 Million outstanding shares. The majority of Indivior PLC Ordinary outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Indivior PLC to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Indivior PLC Ordinary. Please pay attention to any change in the institutional holdings of Indivior PLC Ordinary as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Indivior Ownership Details
Indivior PLC Historical Income Statement
Indivior Stock Against Markets
Indivior PLC Corporate Management
| Jon Fogle | Chief Officer | Profile | |
| Nina DeLorenzo | Chief Officer | Profile | |
| Vishal Kalia | Support Access | Profile | |
| Jason Thompson | Vice Relations | Profile | |
| Kathryn Hudson | Company Secretary | Profile | |
| Christian Heidbreder | Chief Officer | Profile | |
| Richard Simkin | Chief Officer | Profile |
Additional Tools for Indivior Stock Analysis
When running Indivior PLC's price analysis, check to measure Indivior PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indivior PLC is operating at the current time. Most of Indivior PLC's value examination focuses on studying past and present price action to predict the probability of Indivior PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indivior PLC's price. Additionally, you may evaluate how the addition of Indivior PLC to your portfolios can decrease your overall portfolio volatility.